Yap et al. “Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930.” Molecular Cancer Therapeutics 10, no. 2 2011: 360-71. DOI: 10.1158/1535-7163.MCT-10-0760.

Yap et al. “Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930.” Molecular Cancer Therapeutics 10, no. 2 2011: 360-71. DOI: 10.1158/1535-7163.MCT-10-0760.